Table 4.
Association between plasma adiponectin concentration and metabolic syndrome, and the mediation effect of MS components
| OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | OR (95 % CI) | ||
|---|---|---|---|---|---|---|---|
| MetS-IDF | Age (years) | 1.087 (1.052- 1.123) | 1.084 (1.048- 1.122) | 1.088 (1.051- 1.126) | 1.084 (1.045- 1.124) | 1.089 (1.051- 1.128) | 1.075 (1.037- 1.113) |
| Sex (men) | 0.757 (0.404- 1.418) | 0.685 (0.353-1.330) | 0.652 (0.330- 1.290) | 1.656 (0.784- 3.497) | 0.976 (0.487- 1.956) | 0.743 (0.372- 1.486) | |
| Adiponectin (μg/ml) | 0.829 (0.762- 0.902) | 0.870 (0.797-0.949) | 0.837 (0.764- 0.916) | 0.846 (0.769- 0.930) | 0.875 (0.798- 0.958) | 0.894 (0.818- 0.977) | |
| Insulin (mU/L) | - | 1.131 (1.069-1.197) | - | - | - | - | |
| BMI (kg/m2) | - | - | 1.193 (1.113- 1.278) | - | - | - | |
| Waist circumference (cm) | - | - | 1.098 (1.064- 1.133) | - | - | ||
| HDL-cholesterol (mmol/L) | - | - | - | 0.904 (0.873- 0.937) | - | ||
| Triglycerides (mmol/L) | - | - | - | - | 1.020 (1.013- 1.027) | ||
| MetS-AHA/NHLBI | Age (years) | 1.082 (1.047- 1.117) | 1.080 (1.043-1.118) | 1.083 (1.046- 1.122) | 1.078 (1.039- 1.117) | 1.086 (1.047- 1.126) | 1.070 (1.031- 1.110) |
| Sex (men) | 0.803 (0.425- 1.517) | 0.720 (0.366-1.418) | 0.667 (0.331- 1.343) | 1.811 (0.844- 3.886) | 1.103 (0.534- 2.276) | 0.779 (0.377- 1.609) | |
| Adiponectin (μg/ml) | 0.840 (0.772- 0.914) | 0.887 (0.813-0.969) | 0.850 (0.776- 0.931) | 0.861 (0.783- 0.947) | 0.897 (0.817- 0.985) | 0.921 (0.842- 1.007) | |
| Insulin (mU/L) | - | 1.147 (1.083-1.215) | - | - | - | - | |
| BMI (kg/m2) | - | - | 1.212 (1.129- 1.302) | - | - | - | |
| Waist circumference (cm) | - | - | 1.105 (1.070- 1.141) | - | - | ||
| HDL-cholesterol (mmol/L) | - | - | - | 0.884 (0.850- 0.919) | - | ||
| Triglycerides (mmol/L) | - | - | - | - | 1.023 (1.016- 1.031) |